IMAC Holdings Inc

IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Brentwood, TN.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Franklin, TN.

BRENTWOOD, Tenn, Sept. 28, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, has been invited to present at the Fall Harvest – Best Ideas from the Buy-Side conference, which is being held virtually starting October 5, 2021.

IMAC Holdings to Present at Fall Harvest – Best Ideas from the Buy-Side on October 5, 2021

IMAC Holdings, Inc. (IMAC) delivered earnings and revenue surprises of 52.94% and -1.81%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

IMAC Holdings, Inc. (IMAC) Reports Q2 Loss, Misses Revenue Estimates

IMAC reports 36% increase in revenues and 70% increase in patient visits as it invests in value-generating assets

IMAC Holdings Reports Second Quarter 2021 Financial Results

IMAC Holdings, Inc. (IMAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will IMAC Holdings, Inc. (IMAC) Report Negative Q2 Earnings? What You Should Know

BRENTWOOD, Tenn, July 13, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has initiated the second cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson's disease.

IMAC Holdings, Inc. Announces Initiation of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

T he Back Space Continues Its Successful Pilot Program in Tennessee, Expanding into St. Louis

The Back Space Announces Next Spinal Care Locations

Naperville, Ill. purchase to be rebranded Mike Ditka IMAC Regeneration Center

IMAC Holdings Acquires Active Medical Center in Southwestern Chicago Suburb

The Back Space, a newly launched retail spine and neck care subsidiary of IMAC Holdings, Inc. (NASDAQ: IMAC, IMACW), has partnered with Walmart. The unique partnership will make it possible for the Company to provide spinal health and wellness services through its own branded locations directly within select Walmart locations.

The Back Space Partners with Walmart

T he Back Space Grand Opening is the First R etail Location of a Ten Location Pilot Program

IMAC Holdings Introduces The Back Space - First In-Store Chiropractic and Spinal Care Location within Walmart

Brentwood, Tenn., June 02, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced today that Chief Executive Officer Jeffrey Ervin will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 – 10, 2021.

IMAC Holdings to Present at the LD Micro Virtual Invitational Conference on June 8, 2021

BRENTWOOD, Tenn., May 27, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced results from an extensive internal analysis of treatment outcomes for musculoskeletal conditions performed at IMAC Regeneration Centers, which showed approximately 81% of IMAC patients reported improvement in movement, which is consistent with the data measured over the past three years.

IMAC Regeneration Centers Annual Analysis Shows 81% of Patients Report Improvement in Functional Outcomes from Treatment of Musculoskeletal Conditions

Brentwood, Tenn, May 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdin gs, Inc. (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced today that management has been invited to present at the Summer Solstice - Best Ideas from the Buy Side Conference, which is being held virtually on June 1 – June 4, 2021.

IMAC Holdings to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on Tuesday, June 1, 2021

Will IMAC Holdings, Inc. (IMAC) Report Negative Q1 Earnings? What You Should Know

Brentwood, Tenn., April 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitative orthopedic treatments without the use of surgery or opioids, today issued a corporate update in a Letter to Shareholders from CEO Jeff Ervin.

IMAC Holdings CEO Jeff Ervin Provides Corporate Update in Letter to Shareholders

Brentwood, Tenn., April 07, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (the “Company” or “IMAC”) (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced today that it closed the sale of an additional 1,593,750 shares of common stock at the recent public offering price of $1.60 per share, pursuant to the 15% over-allotment option exercised in full by the underwriters in connection with its public offering that closed on March 26, 2021.

IMAC Holdings Announces Full Exercise of Over-Allotment Option of its Public Offering

Brentwood, Tenn., March 26, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (the “Company” or “IMAC”) (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, today closed its previously announced underwritten public offering of 10,625,000 shares of common stock at a public offering price of $1.60 per share, for total gross proceeds of $17.0 million. The net proceeds, after underwriting discounts, but before estimated expenses of the offering payable by IMAC, were approximately $16.0 million. All shares of common stock sold in the offering were sold by the Company, except that the Company, together with its co-founder and chief operating officer as a selling stockholder, granted the underwriter for the offering a 45-day option to purchase up to 15% of the shares of common stock in the offering.

IMAC Holdings Announces Closing of its Public Offering of Common Stock for Total Gross Proceeds of $17.0 Million

Brentwood, Tenn, March 23, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (the “Company” or “IMAC”) (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced today the pricing of its underwritten registered public offering of 10,625,000 shares of its common stock at a public offering price of $1.60 per share, for total gross proceeds of $17.0 million. The net proceeds, after underwriting discounts, but before estimated expenses of the offering payable by IMAC, are expected to be approximately $16.0 million. All shares of common stock to be sold in the offering will be sold by the Company, except that the Company, together with its co-founder and chief operating officer as a selling stockholder, will grant the underwriter for the offering a 45-day option to purchase up to 15% of the shares of common stock in the offering. The offering is expected to close on or about March 26, 2021, subject to the satisfaction of customary closing conditions.

IMAC Holdings Announces Pricing of its Public Offering of Common Stock

BRENTWOOD, Tenn., March 04, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announced financial results for the year ended December 31, 2020.

IMAC Holdings Reports 2020 Financial Results and Corporate Update

BRENTWOOD, Tenn, March 01, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the first cohort of its Phase 1 clinical trial for its investigational compound utilizing umbilical cord-derived allogenic mesenchymal stem cells for the treatment of bradykinesia due to Parkinson's disease.

IMAC Holdings, Inc. Announces Completion of First Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson's Disease

The Back Space will deliver chiropractic and spinal care services in a multi-store test market

IMAC Partners with Fortune 500 Company to Launch In-Store Spinal Care

Insurance to Reimburse Services Providing Cell-Based Amniotic-Infused Mesh Application to Chronic Non-Healing Wounds and Diabetic Foot Ulcers

IMAC Holdings Adds Regenerative Wound Care Service in Regeneration Centers

MEI Pharma

Safe Bulkers

TETRA Technologies

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

5 Stocks to Buy Now Trading Under $10 With Mammoth Upside Potential

BRENTWOOD, Tenn., Jan. 21, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces it has exceeded 1,000 membership enrollments of its health maintenance plans shortly following the one-year anniversary of their introduction on January 3, 2020. The three tiers of health maintenance feature benefits including chiropractic adjustments, spinal decompression visits, and medical evaluations, depending upon the three levels of programs the Company offers.

IMAC Holdings Celebrates One-Year Anniversary of Health Maintenance Plans Surpassing 1,000 Members and Demonstrating Increased Demand for Spinal Wellness Among Its IMAC Regeneration Center Customers

BRENTWOOD, Tenn., Jan. 14, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, today announces it has executed a definitive agreement to acquire assets of NCH Chiropractic, PLLC dba Synergy Healthcare in Orlando, Florida.

IMAC Holdings Expands Florida Presence to Orlando Following Acquisition of Synergy Healthcare

BRENTWOOD, Tenn., Jan. 05, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces its CEO Jeffrey Ervin will present at the H.C. Wainwright Bioconnect 2021 Virtual Conference taking place January 11-14, 2021.

News for IMAC Holdings Inc Stock (IMAC)